A new drug SynriamTM, developed by a team of researchers and considered to be a breakthrough in dealing with cases of malaria, has been approved for treatment of adults in India.

Invented by a team of researchers at the University of Nebraska Medical Center (UNMC), the medicine is considered to be a significant invention, especially in the wake of traditional drugs increasingly proving ineffective against the deadly malarial parasite.